128 related articles for article (PubMed ID: 3568423)
21. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
Sun LP; Gong YH; Wang L; Gong W; Yuan Y
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
[TBL] [Abstract][Full Text] [Related]
22. [Comparative examinations of serum pepsinogen I, II and gastric area using computed radiography in the atrophic gastritis].
Tatsu Y; Ogura Y; Yamazaki K; Nobuhara M; Ishimaru T; Matsui R; Shimizu T; Takeuchi M; Sueyoshi K; Narabayashi I
Kaku Igaku; 1995 Nov; 32(11):1259-62. PubMed ID: 8558795
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens.
Hattori Y; Tashiro H; Kawamoto T; Kodama Y
Jpn J Cancer Res; 1995 Dec; 86(12):1210-5. PubMed ID: 8636012
[TBL] [Abstract][Full Text] [Related]
24. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of serum pepsinogen levels as a screening test for atrophic gastritis and gastric cancer.
Agkoc M; Dursun H; Albayrak F; Yilmaz O; Kiziltunc A; Yilmaz A; Gundogdu C
Eurasian J Med; 2010 Apr; 42(1):15-8. PubMed ID: 25610111
[TBL] [Abstract][Full Text] [Related]
26. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Kitadai Y; Komoto K; Tanaka S; Kajiyama G
Am J Gastroenterol; 1998 Jul; 93(7):1090-6. PubMed ID: 9672336
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of serum pepsinogen I , II and osteopontin co-detection in gastric cancer screening].
Gong YH; Sun LP; Yuan Y
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):691-3. PubMed ID: 17274377
[TBL] [Abstract][Full Text] [Related]
28. [Pepsinogen].
Miki K
Nihon Rinsho; 1995 May; 53(5):1198-202. PubMed ID: 7602778
[TBL] [Abstract][Full Text] [Related]
29. Pepsinogen test for the evaluation of precancerous changes in gastric mucosa: a population-based study.
Sjomina O; Pavlova J; Daugule I; Janovic P; Kikuste I; Vanags A; Tolmanis I; Rudzite D; Polaka I; Kojalo I; Liepniece-Karele I; Isajevs S; Santare D; Pirags V; Pahomova J; Dzerve V; Tzivian L; Erglis A; Leja M
J Gastrointestin Liver Dis; 2018 Mar; 27(1):11-17. PubMed ID: 29557410
[TBL] [Abstract][Full Text] [Related]
30. Pepsinogens I and II in carcinoma of the stomach: an immunohistochemical study.
Stemmermann GN; Samloff IM; Hayashi T
Appl Pathol; 1985; 3(3):159-63. PubMed ID: 3915949
[TBL] [Abstract][Full Text] [Related]
31. Validity of serum pepsinogen levels and quininium resin test combined for gastric cancer screening.
Kim JR; Lee K; Jung WT; Lee OJ; Kim TH; Kim HJ; Lee JS; Passaro DJ
Cancer Detect Prev; 2005; 29(6):570-5. PubMed ID: 16289505
[TBL] [Abstract][Full Text] [Related]
32. Serum pepsinogen levels, Helicobacter pylori CagA Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica.
Con SA; Con-Wong R; Con-Chin GR; Con-Chin VG; Takeuchi H; Valerín AL; Echandi G; Mena F; Brenes F; Yasuda N; Araki K; Sugiura T
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2631-6. PubMed ID: 18086767
[TBL] [Abstract][Full Text] [Related]
33. Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies--with data on peptic ulcer and gastric cancer.
Huang SC; Miki K; Furihata C; Ichinose M; Shimizu A; Oka H
Clin Chim Acta; 1988 Jun; 175(1):37-50. PubMed ID: 3168282
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
[TBL] [Abstract][Full Text] [Related]
35. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
36. Serum pepsinogen in screening for gastric cancer.
Kodoi A; Yoshihara M; Sumii K; Haruma K; Kajiyama G
J Gastroenterol; 1995 Aug; 30(4):452-60. PubMed ID: 7550854
[TBL] [Abstract][Full Text] [Related]
37. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
[TBL] [Abstract][Full Text] [Related]
38. Influence of endoscopic submucosal dissection on serum levels of pepsinogens in patients with early gastric cancer.
Iino C; Shimoyama T; Sasaki Y; Sawaya M; Hanabata N; Fukuda S
Dig Endosc; 2012 Sep; 24(5):339-42. PubMed ID: 22925286
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of serum pepsinogen I and II of patients with gastric cancer].
Kimura Y; Fujii T; Hamamoto K; Miyagawa N; Tsuda K; Tanada S; Iio A
Kaku Igaku; 1989 Sep; 26(9):1127-33. PubMed ID: 2810910
[TBL] [Abstract][Full Text] [Related]
40. Serum pepsinogen as a new marker for gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults.
Kikuchi S; Wada O; Miki K; Nakajima T; Nishi T; Kobayashi O; Inaba Y
Cancer; 1994 Jun; 73(11):2695-702. PubMed ID: 8194008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
